Derivatives marketplace CME Group Inc. (NASDAQ: CME) on Wednesday reported higher earnings and revenues for the second quarter of 2023.
CME Group’s second-quarter revenues increased 10% year-over-year to $1.36 billion, with all three operating segments registering strong growth.
Net income, adjusted for one-off items, increased 17% year-over-year to $2.30 per share during the three-month period. Unadjusted earnings were $767.8 million or $2.14 per share, which is higher than the profit generated in the prior-year period.
“Given ongoing uncertainty in both macroeconomic and geopolitical environments, market participants continued turning to CME Group risk management products and services in Q2, with particularly noteworthy volume increases across our interest rate, commodity, and options contracts,” said CME’s CEO Terry Duffy.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
